InsidersTradesSigma
Follow the ST万邦 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, ST万邦 has logged 2 public disclosures. Market capitalisation: €5.5bn. The latest transaction was filed on 13 October 2025 (Sale). Among the most active insiders: 庄惠. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
ST万邦是一家在XSHE市场上市的医疗保健和制药公司。它专注于药品的开发和销售。